Tag Archives: Analysis Group

Patent Cliff Doom, Gloom Not Panning Out

A lot of ink has flowed describing the tough times that big pharma companies are experiencing as each, lemming-like, tumbles off the patent cliff. Certainly, the pain of shrinking revenues is clear for all to see. AstraZeneca plc, for example,…

Share